MedPath
HSA Approval

Pethidine-hameln Solution for Injection 50mg/ml

SIN14662P

Pethidine-hameln Solution for Injection 50mg/ml

Pethidine-hameln Solution for Injection 50mg/ml

November 14, 2014

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

N02AB02

pethidine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Siegfried Hameln GmbH

Active Ingredients

Pethidine 43.57mg as Pethidine Hydrochloride

50mg

Meperidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.